1Levi F. From circadian to cancer chronotherapeutics [ J]. Chronobiol Internat, 2002, 19( 1 ) :1-19.
2De Vita VT Jr , Hellman S, Rosenberg SA. Cancer: principles and practice of oncology ( sixth edition) [ M]. Philadelphia: JB Lippincott, 2001:21-22.
3Letwin R. Chemosensitivity testing[J]. Clin J Oncol Nurs, 2001,5(5) :195-200.
4Witters LM, Santala SM, Engle L,et al. Decreased response to paclitaxel versus docetaxel in HER -2/neu transfected human breast cancer cells[J]. Am J Clin Oncol, 2003,26(1):50-54.
5Untch M, Ditsch N, Langer E, et al. Chemosensitivity testing in gynecologic oncology——dream or reality [ J ]. Recent Results Cancer Res, 2003,161:146-158.
6Sevin BU, Perras JP, Averette HE,et al. Chemosensitivity testing in ovarian cancer[J]. Cancer, 1993,71 (4) :1613-1620.
7Sevin BU, Peng ZL, Perras JP,et al. Application of an ATP- bioluminescence assay in human tumor chemosensitivity testing[J]. Gynecol Oncol, 1988,31(1): 191-204.
8Sevin BU, Perras JP. Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer[ J]. Am J Obstet Gynecol, 1997, 176(4) :759-766.
9Andreotti PE, Cree IA, Kurbacher CM, et al. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian careinoma[J]. Cancer Res, 1995,55(22):5276-5282.
10Ng TY, Ngan HY, Cheng DK, et al. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum - resistant epithelial ovarian cancer using nonsurgical tumor cell samples[J]. Gynecol Oncol, 2000,76 ( 3 ) :405-408.
5Limburg H.Individual chemotherapy of ovarian cancer by means of tissue and culture method[A].Human tumors in short term culture.Techniques and clinical application[C].London:Acadmic press,1972.295.
6Kaspers CIL,Pieters R,Zantwijk CHV,et al.In vitro drug sensitivity of normal peripheral blood lymphocyte and childhood leakemic from bone marrow and periphera blood.[J].Br J Cancer,1991,64(3):469-474.
9Zaman GJR,Versantvoort CHM,Smit JJM,et al.. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines.Cancer Res,1993,53(8):1 747～1 750.
